Search Results 631-640 of 17187 for Ureaplasma urealyticum

  1. Vasculitis - Doctors and departments - Mayo Clinic

    ... infection. Show more areas of focus for Zach W. Washburn, M.D.. David A. Wetter, M.D.. Dermatologist. Rochester, MN. Areas of focus: Lupus ...

  2. Lyme disease - Doctors and departments - Mayo Clinic

    Learn about the symptoms, diagnosis and treatment of this common tick-borne illness.

  3. A Study of Bacteria Present on the Skin and within the Gastrointestinal Tract and the Connection to Postoperative Infectious Complications - Mayo Clinic

    About this study. The purpose of this study is to better understand why patients get infectious complications after colon or rectal surgery by identifying ...

  4. Leukoplakia - Doctors and departments - Mayo Clinic

    This mouth condition appears as thick, white patches on the gums, the cheeks and the bottom of the mouth that cannot be scraped off.

  5. Medical Research & Education - Mayo Clinic News Network

    Reducing infection from asymptomatic COVID-19 carriers? featured image. COVID-19. Reducing infection from asymptomatic COVID-19 carriers? Robert Nellis.

  6. Hepatitis C Therapeutic Registry and Research Network - Mayo Clinic

    The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic ...

  7. Lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this cancer of the lymphatic system.

  8. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

    Medical condition such as uncontrolled infection (including human immunodeficiency virus [HIV]), uncontrolled diabetes mellitus or cardiac disease which, in ...

  9. General Internal Medicine - Clinical trials

    Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption ...

  10. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

    Uncontrolled infection. Therapy with myelosuppressive chemotherapy or biologic therapy < 21 days prior to registration. NOTE: patients who have recovered ...